×

CEO Interviews

Flexion CEO on developing an alternative to opioids

2 Hours Ago

Dr. Mike Clayman, CEO of Flexion Therapeutics, Inc., discusses the opioid epidemic in the United States and the new solution Flexion has to diminish it.